CMR Surgical Ltd, a British company developing a next-generation surgical robot, on Tuesday announced that it has closed a Series B funding round of $100 million from China’s Zhejiang Silk Road Fund and existing investors Escala Capital Investments, LGT, Cambridge Innovation Capital and Watrium.
Headquartered in Cambridge, UK, CMR Surgical is developing the next-generation universal robotic system, Versius, to make minimal access surgery universally accessible and affordable. About six million people undergo open surgery each year.
